Office for State, Tribal, Local, and Territorial Support, 38655 [2011-16558]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 127 / Friday, July 1, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Office for State, Tribal, Local, and
Territorial Support
mstockstill on DSK4VPTVN1PROD with NOTICES6
In accordance with Presidential
Executive Order No. 13175, November
6, 2000, and the Presidential
Memorandum of November 5, 2009 and
September 23, 2004, Consultation and
Coordination with Indian Tribal
Governments, CDC, OSTLTS announces
the following meeting and Tribal
Consultation Session:
Name: Tribal Advisory Committee (TAC)
Meeting and 7th Biannual Tribal
Consultation Session.
Times and Dates:
8:30 a.m.–5 p.m., August 22–23, 2011 (TAC
Meeting).
8:30 a.m.–4 p.m., August 24, 2011 (7th
Biannual Tribal Consultation Session).
Place: Suquamish Clearwater Casino
Resort, 15347 Suquamish Way, NE.,
Suquamish, Washington 98392.
Status: All meetings are being hosted by
the Northwest Portland Area Indian Health
Board and are open to the public. August 23,
2011, has been reserved as a day to tour and
interact with local Tribes. A special
invitation has been extended to the
Washington and Oregon American Indian
Tribal Leaders, Washington and Oregon State
Health Department Officials, and all
American Indian/Alaska Native (AI/AN)
Tribal leaders from across the nation.
Purpose: CDC released its Tribal
Consultation Policy in October of 2005 with
the primary purpose of providing guidance
across the agency to work effectively with AI/
AN tribes, communities, and organizations to
enhance AI/AN access to CDC resources and
programs. In November of 2006, an Agency
Advisory Committee (the CDC/Agency for
Toxic Substances and Disease Registry Tribal
Advisory Committee—TAC) was established
to provide a complementary venue wherein
tribal representatives and CDC staff could
exchange information about public health
issues in Indian Country, identifying urgent
public health needs in AI/AN communities,
and discuss collaborative approaches to these
issues and needs. Within the CDC
Consultation Policy, it is stated that CDC will
conduct government-to-government
consultation with elected tribal officials or
their designated representatives and confer
with tribal and American Native
organizations and AI/AN urban and rural
communities before taking actions and or
making decisions that affect them.
Consultation is an enhanced form of
communication that emphasizes trust,
respect, and shared responsibility. It is an
open and free exchange of information and
opinion among parties that leads to mutual
understanding and comprehension. CDC
believes that consultation is integral to a
deliberative process that results in effective
collaboration and informed decision making
VerDate Mar<15>2010
18:54 Jun 30, 2011
Jkt 223001
with the ultimate goal of reaching consensus
on issues. Although formal responsibility for
the agency’s overall government-togovernment consultation activities rests
within the CDC Office of the Director (OD),
other CDC Centers, Institutes, and Offices,
leadership shall actively participate in TAC
meetings and HHS-sponsored regional and
national tribal consultation sessions as
frequently as possible.
Matters to be Discussed: The TAC will
convene their advisory committee meeting
with discussions and presentations from
various CDC senior leaderships on activities
and areas identified by TAC members and
other tribal leaders as priority public health
issues. The Biannual Tribal Consultation
Session will engage CDC Senior leadership
from the CDC OD and various CDC Centers,
Institutes and Offices, including the
Financial Management Office, the Office of
the Associate Director of Communications,
OSTLTS, the National Center for
Environmental Health and the Agency for
Toxic Substances and Disease Registry, the
National Center for Chronic Disease
Prevention and Health Promotion, as well as
others. Opportunities will be provided
during the consultation session for tribal
testimony. Tribal Leaders are encouraged to
submit written testimony by close of business
on August 5, 2011, to the contact person
listed below.
It may be necessary to limit the time of
each presenter due to the availability of time.
The agenda is subject to change as
priorities dictate.
Information about TAC and CDC’s Tribal
Consultation Policy and previous meetings
may be referenced on the following Web link:
https://www.cdc.gov/ostlts/
tribal_public_health/announcements.html.
Contact Person for more Information:
Kimberly Cantrell, Public Health Advisor,
Tribal Support, OSTLTS, CDC, 1600 Clifton
Road, NE., MS K–70, Atlanta, Georgia 30333,
telephone (404) 498–0411, e-mail:
KLW6@cdc.gov.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: June 24, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–16558 Filed 6–30–11; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
38655
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10398, CMS–
10399, CMS–10137, and CMS–10237]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection; Title of
Information Collection: Generic
Clearance for Medicaid and CHIP State
Plan, Waiver, and Program Submissions;
Use: CMS is requesting a generic PRA
clearance for a body of forms necessary
to conduct ongoing business with State
partners in the implementation of
Medicaid and the Children’s Health
Insurance Program (CHIP). The specific
forms have not yet been developed but
will be developed over the 3-year
approval period. The types of forms to
be produced in this collection include
State plan amendment templates,
waiver and demonstration templates,
and reporting templates. The
development of streamlined submission
forms is critical for States to implement
timely health reform initiatives in
Medicaid and CHIP state plans,
demonstrations, and waivers, including
legislative requirements enacted by the
Affordable Care Act. The development
of streamlined submissions forms
enhances the collaboration and
partnership between States and CMS by
documenting CMS policy for States to
use as they are developing program
changes. Streamlined forms improve
efficiency of administration by creating
E:\FR\FM\01JYN1.SGM
01JYN1
]]>Agencies
[Federal Register Volume 76, Number 127 (Friday, July 1, 2011)]
[Notices]
[Page 38655]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16558]
[[Page 38655]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Office for State, Tribal, Local, and Territorial Support
In accordance with Presidential Executive Order No. 13175, November
6, 2000, and the Presidential Memorandum of November 5, 2009 and
September 23, 2004, Consultation and Coordination with Indian Tribal
Governments, CDC, OSTLTS announces the following meeting and Tribal
Consultation Session:
Name: Tribal Advisory Committee (TAC) Meeting and 7th Biannual
Tribal Consultation Session.
Times and Dates:
8:30 a.m.-5 p.m., August 22-23, 2011 (TAC Meeting).
8:30 a.m.-4 p.m., August 24, 2011 (7th Biannual Tribal Consultation
Session).
Place: Suquamish Clearwater Casino Resort, 15347 Suquamish Way,
NE., Suquamish, Washington 98392.
Status: All meetings are being hosted by the Northwest Portland
Area Indian Health Board and are open to the public. August 23,
2011, has been reserved as a day to tour and interact with local
Tribes. A special invitation has been extended to the Washington and
Oregon American Indian Tribal Leaders, Washington and Oregon State
Health Department Officials, and all American Indian/Alaska Native
(AI/AN) Tribal leaders from across the nation.
Purpose: CDC released its Tribal Consultation Policy in October
of 2005 with the primary purpose of providing guidance across the
agency to work effectively with AI/AN tribes, communities, and
organizations to enhance AI/AN access to CDC resources and programs.
In November of 2006, an Agency Advisory Committee (the CDC/Agency
for Toxic Substances and Disease Registry Tribal Advisory
Committee--TAC) was established to provide a complementary venue
wherein tribal representatives and CDC staff could exchange
information about public health issues in Indian Country,
identifying urgent public health needs in AI/AN communities, and
discuss collaborative approaches to these issues and needs. Within
the CDC Consultation Policy, it is stated that CDC will conduct
government-to-government consultation with elected tribal officials
or their designated representatives and confer with tribal and
American Native organizations and AI/AN urban and rural communities
before taking actions and or making decisions that affect them.
Consultation is an enhanced form of communication that
emphasizes trust, respect, and shared responsibility. It is an open
and free exchange of information and opinion among parties that
leads to mutual understanding and comprehension. CDC believes that
consultation is integral to a deliberative process that results in
effective collaboration and informed decision making with the
ultimate goal of reaching consensus on issues. Although formal
responsibility for the agency's overall government-to-government
consultation activities rests within the CDC Office of the Director
(OD), other CDC Centers, Institutes, and Offices, leadership shall
actively participate in TAC meetings and HHS-sponsored regional and
national tribal consultation sessions as frequently as possible.
Matters to be Discussed: The TAC will convene their advisory
committee meeting with discussions and presentations from various
CDC senior leaderships on activities and areas identified by TAC
members and other tribal leaders as priority public health issues.
The Biannual Tribal Consultation Session will engage CDC Senior
leadership from the CDC OD and various CDC Centers, Institutes and
Offices, including the Financial Management Office, the Office of
the Associate Director of Communications, OSTLTS, the National
Center for Environmental Health and the Agency for Toxic Substances
and Disease Registry, the National Center for Chronic Disease
Prevention and Health Promotion, as well as others. Opportunities
will be provided during the consultation session for tribal
testimony. Tribal Leaders are encouraged to submit written testimony
by close of business on August 5, 2011, to the contact person listed
below.
It may be necessary to limit the time of each presenter due to
the availability of time.
The agenda is subject to change as priorities dictate.
Information about TAC and CDC's Tribal Consultation Policy and
previous meetings may be referenced on the following Web link:
https://www.cdc.gov/ostlts/tribal_public_health/announcements.html.
Contact Person for more Information: Kimberly Cantrell, Public
Health Advisor, Tribal Support, OSTLTS, CDC, 1600 Clifton Road, NE.,
MS K-70, Atlanta, Georgia 30333, telephone (404) 498-0411, e-mail:
KLW6@cdc.gov.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention,
and the Agency for Toxic Substances and Disease Registry.
Dated: June 24, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-16558 Filed 6-30-11; 8:45 am]
BILLING CODE 4163-18-P
